Tiago Girao, Chief Financial Officer, on July 23, 2026, sold 6,798 shares in Immunovant (IMVT) for $263,015. Following the Form 4 filing with the SEC, Girao has control over a total of 240,798 common shares of the company, with 240,798 shares held directly.
SEC Filing: